Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Are we on the cusp of an AI revolution?

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pharmaceutical industry has historically been slow to adapt to change, with high regulatory hurdles and widespread scepticism facing new …
Feature

Navigating through the post-COVID-19 R&D bottleneck

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Jack Goddard inve
Feature
pexels-matthias-zomer-339620

Study finds superior outcomes for fracture risk reduction in osteoporosis

April 26, 2021 Sales and Marketing

A real-world evidence study, presented at the International Conference on Osteoporosis, Arthritis and Musculoskeletal Disorders, has shown for the first …
News

Dermavant Sciences announce data of two Phase III trials for psoriasis

April 26, 2021 Sales and Marketing

Dermavant Sciences have presented successful data from two Phase III trials for tapinarof, for the treatment of psoriasis in adults, …
News
credit_-_daniel_leal-olivas-afp

LEO Pharma receives positive CHMP opinion for dermatitis treatment

April 26, 2021 Sales and Marketing CHMP, EMA, EU, dermatitis

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion …
News
sanofi_hq__boetie_hall_web

Sanofi’s RSV drug sees Phase III clinical trial success

April 26, 2021 Sales and Marketing AstraZeneca, Sanofi

Sanofi have announced positive topline results from the Phase III MELODY trial into nirsevimab, which demonstrated protection against respiratory syncytial …
News

Phoenix Cardiac gains CE Mark for “game-changer” MR device

April 26, 2021 Sales and Marketing CE Mark, EU, cardiovascular

Phoenix Cardiac Devices have received CE Mark certification for its BACE (basal annuloplasty of the cardia externally) device, a novel …
News
Eli Lilly front sign

Lilly’s COVID-19 drug has EUA revoked in favour of combination therapy

April 19, 2021 Sales and Marketing COVID-19, Eli Lilly, FDA, covid-19 treatment, lilly, pharma, pharma news

The FDA have revoked Emergency Use Authorization (EUA) of Eli Lilly’s bamlanivimab drug for the treatment of COVID-19, per the …
News

NICE launch ambitious five-year patient access strategy

April 19, 2021 Sales and Marketing NICE

NICE has unveiled its five-year plan to speed up patients’ access to the latest and most effective treatments with increased …
News

Sanofi signs €414 million deal for C4XD oral IL-17A inhibitor programme

April 19, 2021 Sales and Marketing Sanofi

Sanofi has signed an exclusive worldwide licensing agreement with C4X Discovery Limited for C4XD’s oral pre-clinical IL-17A inhibitor programme, which …
News

Sanofi multiple myeloma drug approved for second indication by EC

April 19, 2021 Sales and Marketing European Commission, Sanofi, Sarclisa, pharma, pharma news

The European Commission (EC) has approved a second indication of Sanofi’s Sarclisa drug for the treatment of adult patients with …
News
pfizer

Pfizer vaccine: Study finds increased breakthrough rates of South African variant

April 19, 2021 Sales and Marketing COVID-19, Pfizer, Vaccine, variant

A study published by Tel Aviv University has found an increased breakthrough rate of the South African variant of COVID-19 …
News

Sanofi to invest €400 million on Singapore vaccine production site

April 12, 2021 Sales and Marketing Sanofi, Vaccine

Sanofi have today announced a €400 million investment to create a unique vaccine production centre in Singapore, in partnership with …
News

EMA launch investigation into J&J’s COVID-19 vaccine amid US blood clot reports

April 12, 2021 Sales and Marketing COVID-19, EMA, J&J, JJ, Vaccine

The EMA is reviewing reports of rare blood clots in four people in the US who received Johnson & Johnson’s …
News

Immutep achieves FDA Fast Track designation for soluble LAG-3 protein

April 12, 2021 Sales and Marketing FDA, HNSCC

Immutep, a biotechnology company developing novel immunotherapy treatments for cancer, infectious disease, and autoimmune disease, has achieved FDA Fast Track …
News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026